1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Meningococcal Immunisation: new trials by email Literature Review of Meningococcal Immunisation trials Research Report on Meningococcal Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine - Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Active not recruiting | Sanofi Pasteur, a Sanofi Company | 209 | 2022-08-23 | 2026-08-28 |
Sanofi Pasteur, a Sanofi Company (1)
Finland (1) · Germany (1) · Hungary (1) · Spain (1)
2023 (1)